Participants dealing with the challenges of Chronic Obstructive Pulmonary Disease (COPD) have a potential new option in the form of a medication called Solrikitug. In this clinical study, the focus is on evaluating the safety of this medicine, how well it’s tolerated by participants, and its overall effects on the body when taken alongside the typical treatments for COPD. The investigation will assess the effect of multiple doses of Solrikitug on blood eosinophil counts.